Latest news
Loading news…
SYLENTIS, biotech company focused on the development of new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
3
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Madrid, Spain
Key People at SYLENTIS
Founder & CEO
Clinical Operations Manager
3
professional contacts at SYLENTIS
Contact execs at SYLENTIS →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to SYLENTIS
Loading news…
FAQs about SYLENTIS
People who checked this page also checked these
Browse the full Acquirezy directory.